- Accuray
Sunnyvale, California (ots/PRNewswire) - Accuray Incorporated (Nasdaq: ARAY) announced today the unveiling of a new corporate website that reflects the company's evolution and leadership in patient-first cancer...
- 15.05.2018, 13:37:43
- /
- OTE0007
- Accuray
Sunnyvale, Kalifornien (ots/PRNewswire) - Einzigartige Hologramm-Technologie präsentiert die Vorteile von Accurays Strahlentherapiesystemen und Softwarelösungen für Patienten
- 17.04.2018, 13:32:42
- /
- OTS0159
- Accuray
Sunnyvale, California (ots/PRNewswire) - CyberKnife Frameless Radiosurgery Offers a Precise and Non-Invasive Technique with Clinical Outcomes Similar to Gamma Knife Frame-Based Invasive Radiosurgery
- 29.01.2018, 13:35:40
- /
- OTE0003
- Accuray
Sunnyvale, California (ots/PRNewswire) - Accuray Incorporated (NASDAQ: ARAY) announced today that the Court of Appeal of Nantes has rejected the appeal filed by Varian Medical Systems opposing the purchase of the...
- 19.10.2017, 13:33:42
- /
- OTE0004
- Accuray
Sunnyvale, California (ots/PRNewswire) - First Study to Evaluate the Use of Stereotactic Body Radiation Therapy in Low-Risk Prostate Cancer 10 Years Post Treatment
- 26.09.2017, 13:32:41
- /
- OTE0003
- Accuray
Sunnyvale, California (ots/PRNewswire) - Accuray Incorporated (NASDAQ: ARAY) announced today that data and first-hand experience with its advanced CyberKnife® and Radixact(TM) Systems (http://www.accuray.com/product-overview)...
- 20.09.2017, 22:17:43
- /
- OTE0010
- Accuray
Sunnyvale, California (ots/PRNewswire) - Prospective, Multicenter Study Supported by the French National Institute of Cancer Also Demonstrates that Treatment with the TomoTherapy Platform Resulted in a Significantly...
- 20.07.2017, 13:32:40
- /
- OTE0003
- Accuray
Sunnyvale, California (ots/PRNewswire) - The French Cancer Institute is Building its Re-irradiation and Adaptive Radiotherapy Program Using the Latest Technology Developed by Accuray
- 20.06.2017, 13:32:12
- /
- OTE0004
- Accuray
Sunnyvale, California (ots/PRNewswire) - Multiple Studies Presented at ESTRO 36 Demonstrate System Improves Tumor Control with Reduced Toxicities
- 11.05.2017, 13:42:40
- /
- OTE0008
- Accuray
Sunnyvale, California (ots/PRNewswire) - Studies Show the System Provides Excellent Outcomes Throughout the Cancer Treatment Journey, from Primary Cases to Recurrence and Metastatic Disease
- 11.05.2017, 13:32:40
- /
- OTE0007

